FDA Says Sanofi Misrepresented RSV Shot’s Indication The U.S. Food and Drug Administration has accused Sanofi of making misleading promotional claims about its RSV monoclonal antibody Beyfortus. According to an Untitled Letter issued by the agency, Sanofi’s promotional emails created a “misleading impression” about the approved use of the drug. The FDA stated that Sanofi […]
The Verdict
ClassificationLikely Human
ConfidenceMedium confidence
Analyzedtext
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/2cef9367-6f97-4d9f-8521-fec1ff99226b)